BR112022009402A2 - Nanoporos artificiais e usos e métodos relacionados com os mesmos - Google Patents

Nanoporos artificiais e usos e métodos relacionados com os mesmos

Info

Publication number
BR112022009402A2
BR112022009402A2 BR112022009402A BR112022009402A BR112022009402A2 BR 112022009402 A2 BR112022009402 A2 BR 112022009402A2 BR 112022009402 A BR112022009402 A BR 112022009402A BR 112022009402 A BR112022009402 A BR 112022009402A BR 112022009402 A2 BR112022009402 A2 BR 112022009402A2
Authority
BR
Brazil
Prior art keywords
methods
nanopores
artificial
related uses
subunit
Prior art date
Application number
BR112022009402A
Other languages
English (en)
Inventor
Maglia Giovanni
Zhang Shengli
Original Assignee
Univ Groningen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Groningen filed Critical Univ Groningen
Publication of BR112022009402A2 publication Critical patent/BR112022009402A2/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/48707Physical analysis of biological material of liquid biological material by electrical means
    • G01N33/48721Investigating individual macromolecules, e.g. by translocation through nanopores
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2565/00Nucleic acid analysis characterised by mode or means of detection
    • C12Q2565/60Detection means characterised by use of a special device
    • C12Q2565/631Detection means characterised by use of a special device being a biochannel or pore

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Nanotechnology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

NANOPOROS ARTIFICIAIS E USOS E MÉTODOS RELACIONADOS COM OS MESMOS. A invenção se refere ao campo de nanoporos e seu uso na análise de biopolímeros, incluindo polipeptídeos e polinucleotídeos. É fornecido um nanoporo artificial compreendendo um conjunto multimérico de subunidades, cada subunidade compreendendo (i) a sequência transmembranar (TM) de uma proteína formadora de poros ß-barril ou a-helicoidal fundida com a sequência de aminoácidos de (ii) uma subunidade de uma proteína formadora de anel capaz de controlar o transporte de um polipeptídeo ou polinucleotídeo através da região TM do conjunto.
BR112022009402A 2019-11-19 2020-11-19 Nanoporos artificiais e usos e métodos relacionados com os mesmos BR112022009402A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19210168 2019-11-19
PCT/NL2020/050726 WO2021101378A1 (en) 2019-11-19 2020-11-19 Artificial nanopores and uses and methods relating thereto

Publications (1)

Publication Number Publication Date
BR112022009402A2 true BR112022009402A2 (pt) 2022-08-09

Family

ID=68840857

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022009402A BR112022009402A2 (pt) 2019-11-19 2020-11-19 Nanoporos artificiais e usos e métodos relacionados com os mesmos

Country Status (11)

Country Link
US (2) US20220412948A1 (pt)
EP (1) EP4061965A1 (pt)
JP (1) JP2023502658A (pt)
KR (1) KR20220100901A (pt)
CN (1) CN114981450A (pt)
AU (1) AU2020389020A1 (pt)
BR (1) BR112022009402A2 (pt)
CA (1) CA3161981A1 (pt)
IL (1) IL293024A (pt)
MX (1) MX2022006018A (pt)
WO (1) WO2021101378A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3111488A1 (en) 2018-09-11 2020-03-19 Rijksuniversiteit Groningen Biological nanopores having tunable pore diameters and uses thereof as analytical tools
WO2023225988A1 (zh) * 2022-05-27 2023-11-30 深圳华大生命科学研究院 一种维持纳米孔测序速度的方法
WO2024091124A1 (en) 2022-10-28 2024-05-02 Rijksuniversiteit Groningen Nanopore-based analysis of proteins
WO2024091123A1 (en) 2022-10-28 2024-05-02 Rijksuniversiteit Groningen Nanopore systems and methods for single-molecule polymer profiling
CN117417421B (zh) * 2023-01-12 2024-07-23 北京普译生物科技有限公司 一种突变体膜蛋白复合物纳米孔及其应用
WO2024205413A1 (en) * 2023-03-30 2024-10-03 Rijksuniversiteit Groningen Large conical nanopores and uses thereof in analyte sensing

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103695530B (zh) 2008-07-07 2016-05-25 牛津纳米孔技术有限公司 酶-孔构建体
FR3003268B1 (fr) 2013-03-13 2018-01-19 Roquette Freres Bioreacteur
JP7237586B2 (ja) * 2015-12-08 2023-03-13 カトリック ユニヴェルシテット ルーヴェン カーユー ルーヴェン リサーチ アンド ディベロップメント 修飾ナノポア、それを含む組成物およびその使用
EP3423485B1 (en) * 2016-03-02 2021-12-29 Oxford Nanopore Technologies plc Mutant pore
CN109890980A (zh) 2016-07-12 2019-06-14 格罗宁根大学 基于FraC actinoporin的用于生物聚合物传感和测序的生物纳米孔
GB201809323D0 (en) * 2018-06-06 2018-07-25 Oxford Nanopore Tech Ltd Method

Also Published As

Publication number Publication date
KR20220100901A (ko) 2022-07-18
US20220412948A1 (en) 2022-12-29
CA3161981A1 (en) 2021-05-27
CN114981450A (zh) 2022-08-30
JP2023502658A (ja) 2023-01-25
US20240288416A1 (en) 2024-08-29
MX2022006018A (es) 2022-09-12
WO2021101378A1 (en) 2021-05-27
EP4061965A1 (en) 2022-09-28
AU2020389020A1 (en) 2022-06-09
IL293024A (en) 2022-07-01

Similar Documents

Publication Publication Date Title
BR112022009402A2 (pt) Nanoporos artificiais e usos e métodos relacionados com os mesmos
Torra et al. Overexpression of TFEB drives a pleiotropic neurotrophic effect and prevents Parkinson’s disease-related neurodegeneration
BR112019001108A2 (pt) usos de vesículas extracelulares compreendendo uma proteína de fusão tendo capacidade de ligação a fc
BR112017020986A2 (pt) proteínas de ligação recombinantes e seu uso
BR112018001353A2 (pt) construtos tendo um domínio de sirp-alfa ou variante do mesmo
Skjesol et al. Structural and functional studies of STAT1 from Atlantic salmon (Salmo salar)
BR112021018776A2 (pt) Vetores de vírus adenoassociado recombinante
BR112021000811A8 (pt) Agonistas de il2
Fan et al. Zebrafish TRIF, a Golgi-localized protein, participates in IFN induction and NF-κB activation
BR112018073511A2 (pt) polipeptídeos seletivos do receptor de glucagon e métodos de uso dos mesmos
JP2019507583A5 (pt)
BR112016027805A2 (pt) receptores de células t do anti-papilomavírus humano 16 e7
GT201000148A (es) Anticuerpos antimesotelina y usos de los mismos
EA201990900A1 (ru) Стабильный при комнатной температуре лиофилизированный белок
NO20090818L (no) Humant endogent retrovirus polypeptid sammensetninger samt anvendelsesmetoder derav
Pulkki et al. The bioactivity of human bone morphogenetic protein-15 is sensitive to C-terminal modification: characterization of the purified untagged processed mature region
BR112019000680A2 (pt) nanoporos biológicos para detecção de biopolímeros e sequenciamento baseado em actinoporina fragaceatoxina c
BR112018071686A2 (pt) exibição de proteínas integrais de membrana em vírions extracelulares envelopados de poxvírus
BR112017008525A2 (pt) proteína de fusão isolada, e, métodos para tratamento ou alívio de um sintoma de uma doença ou distúrbio, para tratamento ou alívio de uma inflamação ou um sintoma de uma doença ou distúrbio inflamatório e para redução do risco de infecção em um indivíduo.
Yan et al. TBK1 of black carp plays an important role in host innate immune response against SVCV and GCRV
BR112022010153A2 (pt) Peptídeos, ácido nucleico, polipeptídeo, composição, complexo bioluminescente, métodos, dipeptídeo, sistema e kit
MX2023008351A (es) Heterodimeros de proteinas de membrana tipo i y metodos de uso de los mismos.
CN106967696A (zh) 一种蒿属植物花粉的过敏原及其应用
BR112017022076A2 (pt) fusões de mesotelina-variante iii de receptor de fator de crescimento epidérmico e métodos de uso das mesmas
MA53293A (fr) Protéines de liaison multi-spécifiques se liant à bcma, nkg2d et cd16, et méthodes d'utilisation